
AILIS is an innovative breast health monitoring system that utilizes advanced AI algorithms and Dynamic Parametric Imaging (DPI) technology to provide non-invasive, painless breast cancer detection. The system is designed to be quick and efficient, requiring minimal staff involvement while ensuring comfort and privacy for women. With a focus on addressing the challenges of dense breast tissue, AILIS aims to revolutionize early breast cancer detection and expand access to effective screening methods globally. Currently undergoing clinical evaluation, AILIS is positioned to make a significant impact in women's health and has received substantial funding to support its development and market entry.

AILIS is an innovative breast health monitoring system that utilizes advanced AI algorithms and Dynamic Parametric Imaging (DPI) technology to provide non-invasive, painless breast cancer detection. The system is designed to be quick and efficient, requiring minimal staff involvement while ensuring comfort and privacy for women. With a focus on addressing the challenges of dense breast tissue, AILIS aims to revolutionize early breast cancer detection and expand access to effective screening methods globally. Currently undergoing clinical evaluation, AILIS is positioned to make a significant impact in women's health and has received substantial funding to support its development and market entry.
Product: Non-contact AI-driven breast health monitoring system using Dynamic Parametric Imaging (DPI)
Stage: Undergoing clinical evaluation and preparing for regulatory certification
Founded / HQ: Founded 2016; Kraków, Poland
Team size (reported): About 24 employees
Funding (reported): Total disclosed ~3.43M USD; latest round: grant (Dec 20, 2021)
Early breast cancer detection and monitoring, including challenges with dense breast tissue
2016
Medtech / Healthcare
Latest disclosed financing listed as a grant
1621000.00
Seed round entry listed on company funding timeline
1216000.00
“Received grant and public R&D funding from Polish/National research agencies and support from business angels”